Medicine
Protopam Chloride 1 g/20 mL powder for injection
Protopam Chloride 1 g/20 mL powder for injection is a prescription medicine containing Pralidoxime for intramuscular, intravenous, subcutaneous use, marketed by Baxter Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F).
Key facts
- Active ingredient (INN)
- Pralidoxime
- Brand
- Protopam Chloride
- Strength
- 1 g/20 mL
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous, subcutaneous
- Packs
- 6 vials
- Marketing authorisation holder
- Baxter Healthcare
- Manufacturer
- Baxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AB04 Pralidoxime
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 March 1965
- Identifiers
- RxCUI 208969, 312576DailyMed set ID 2741d8fd-51c2-46be-880b-99f2b20a6137NDC 60977-141Application NDA014134
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 vial, single-dose in 1 package / 20 mL in 1 vial, single-dose | 60977-141-01 | Baxter Healthcare | 10 March 1965 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 March 1964 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Pralidoxime is a cholinesterase reactivator indicated as an antidote. It is available as powder for injection for intramuscular, intravenous and subcutaneous use. MedsAcross supplies Pralidoxime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PralidoximeFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Protopam Chloride prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Protopam Chloride 1 g/20 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.